Takata Y, Tamura N, Fujita T
J Immunol. 1984 May;132(5):2531-7.
The binding properties of activated C3 to immune complexes were studied by using solubilization phenomenon as a model system. IgG or F(ab')2 immune precipitates were solubilized by the six isolated alternative pathway proteins, and the solubilized complexes were analyzed by SDS-PAGE. As a result of solubilization, we observed some high m.w. bands. Under reducing conditions, the bands with m.w. of 150,000 and 115,000 appeared in the case of IgG and F(ab')2 complexes, respectively. Two-dimensional SDS-PAGE revealed that hydroxylamine treatment resulted in the dissociation of the 150,000-m.w. polypeptide into the C3 alpha-65 and the heavy chain of IgG. Similarly, the 115,000-m.w. polypeptide was dissociated into the C3 alpha-65 and the Fd chain. Therefore, it is likely that iC3b binds covalently to the Fd region of the heavy chain of IgG via an ester bond. Under nonreducing conditions, iC3b-IgG and iC3b-F(ab')2 complexes had apparent m.w. of 340,000 and 270,000, respectively, corresponding to one iC3b molecule bound to one antibody molecule. In addition, a considerable amount of iC3b also binds to antigen molecules via an ester bond. The findings that C3 binds to the F(ab')2 molecules and bovine serum albumin, which contain only a small amount of carbohydrate, suggest that C3 may not bind to the carbohydrate moiety of antibody molecules. Indeed, various carbohydrate molecules did not inhibit the solubilization even at high concentrations. In contrast, acetyl tyrosine having an aromatic ring and a hydroxyl group produced the best inhibition of the solubilization. Furthermore, we demonstrated that generation of C3b in the presence of 3H-tyrosine resulted in covalent binding of the tyrosine specifically to the C3 alpha' chain, indicating that the inhibition of solubilization may be due to the competition between tyrosine and immune complexes for the covalent binding of C3. Thus, it could be concluded that C3 binds covalently to the amino acid residues of antigen and antibody molecules during solubilization.
以溶解现象作为模型系统,研究了活化补体C3与免疫复合物的结合特性。用六种分离的替代途径蛋白溶解IgG或F(ab')2免疫沉淀物,并用SDS-PAGE分析溶解的复合物。溶解的结果是,我们观察到一些高分子量条带。在还原条件下,IgG和F(ab')2复合物分别出现分子量为150,000和115,000的条带。二维SDS-PAGE显示,羟胺处理导致150,000分子量的多肽解离为C3α-65和IgG重链。同样,115,000分子量的多肽解离为C3α-65和Fd链。因此,iC3b可能通过酯键与IgG重链的Fd区域共价结合。在非还原条件下,iC3b-IgG和iC3b-F(ab')2复合物的表观分子量分别为340,000和270,000,对应于一个iC3b分子与一个抗体分子结合。此外,相当数量的iC3b也通过酯键与抗原分子结合。C3与仅含少量碳水化合物的F(ab')2分子和牛血清白蛋白结合的发现表明,C3可能不与抗体分子的碳水化合物部分结合。事实上,即使在高浓度下,各种碳水化合物分子也不抑制溶解。相反,具有芳香环和羟基的乙酰酪氨酸对溶解的抑制作用最佳。此外,我们证明在3H-酪氨酸存在下生成C3b会导致酪氨酸特异性地与C3α'链共价结合,表明溶解的抑制可能是由于酪氨酸与免疫复合物在C3共价结合上的竞争。因此,可以得出结论,在溶解过程中C3与抗原和抗体分子的氨基酸残基共价结合。